Jiju Mani

651 total citations
19 papers, 492 citations indexed

About

Jiju Mani is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Jiju Mani has authored 19 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Jiju Mani's work include CAR-T cell therapy research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Peptidase Inhibition and Analysis (4 papers). Jiju Mani is often cited by papers focused on CAR-T cell therapy research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Peptidase Inhibition and Analysis (4 papers). Jiju Mani collaborates with scholars based in Germany, China and India. Jiju Mani's co-authors include Michael Schmitt, Nan Jin, Anita Schmitt, Suman Kapila, Pramod Upadhyay, Sangeeta Bhaskar, Prashant Singh, Ramya Iyer, Sudhir Kumar Tomar and Pawan Kumar and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Jiju Mani

18 papers receiving 468 citations

Peers

Jiju Mani
Christopher Oelkrug Germany
Rajwardhan Yadav United States
Michaela Friedrichsen Germany
Mingju Hao China
Nichole Escalante Canada
Adovi Akue United States
Steven A. Erickson United States
Maureen L. Drakes United States
Richard B. Sisson United States
Jihoon Chang United States
Christopher Oelkrug Germany
Jiju Mani
Citations per year, relative to Jiju Mani Jiju Mani (= 1×) peers Christopher Oelkrug

Countries citing papers authored by Jiju Mani

Since Specialization
Citations

This map shows the geographic impact of Jiju Mani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiju Mani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiju Mani more than expected).

Fields of papers citing papers by Jiju Mani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiju Mani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiju Mani. The network helps show where Jiju Mani may publish in the future.

Co-authorship network of co-authors of Jiju Mani

This figure shows the co-authorship network connecting the top 25 collaborators of Jiju Mani. A scholar is included among the top collaborators of Jiju Mani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiju Mani. Jiju Mani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sasikumar, Pottayil G., Raghuveer Ramachandra, Dodderi S. Samiulla, et al.. (2021). PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy. Communications Biology. 4(1). 699–699. 118 indexed citations
2.
Sasikumar, Pottayil G., et al.. (2019). Abstract 4148: An orally bioavailable small molecule antagonist of TIM-3 signaling pathway shows potent anti-tumor activity. Cancer Research. 79(13_Supplement). 4148–4148. 1 indexed citations
3.
Sasikumar, Pottayil G., et al.. (2018). Abstract B006: Functional antagonism of VSIG8-mediated immune suppression by oral VISTA agents. Molecular Cancer Therapeutics. 17(1_Supplement). B006–B006. 10 indexed citations
4.
Wang, Lei, Angela Hückelhoven, Jian Hong, et al.. (2016). Standardization of cryopreserved peripheral blood mononuclear cells through a resting process for clinical immunomonitoring—Development of an algorithm. Cytometry Part A. 89(3). 246–258. 36 indexed citations
5.
Sasikumar, Pottayil G., Dodderi S. Samiulla, Raghuveer Ramachandra, et al.. (2016). Abstract 4861: Oral immune checkpoint antagonists targeting PD-L1/VISTA or PD-L1/Tim3 for cancer therapy. Cancer Research. 76(14_Supplement). 4861–4861. 11 indexed citations
6.
Mani, Jiju, Lei Wang, Angela Hückelhoven, et al.. (2016). Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance. Oncotarget. 8(2). 2485–2500. 9 indexed citations
7.
Sasikumar, Pottayil G., Raghuveer Ramachandra, Dodderi S. Samiulla, et al.. (2016). Pre-clinical efficacy in multiple syngeneic models with oral immune checkpoint antagonists targeting PD-L1 and TIM-3. European Journal of Cancer. 69. S98–S98. 4 indexed citations
8.
Lorenz, Katrin, Jiju Mani, Nan Jin, et al.. (2014). Modulation of lymphocyte subpopulations by extracorporeal photopheresis in patients with acute graft-versus-host disease or graft rejection. Leukemia & lymphoma. 56(3). 671–675. 11 indexed citations
9.
Mani, Jiju, Nan Jin, & Michael Schmitt. (2014). Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation. Cytotherapy. 16(10). 1325–1335. 26 indexed citations
10.
Schmitt, Michael, Kim Orchard, Matthias Görlach, et al.. (2014). Biosimilar G-CSF Based Mobilization of Peripheral Blood Hematopoietic Stem Cells for Autologous and Allogeneic Stem Cell Transplantation. Theranostics. 4(3). 280–289. 41 indexed citations
11.
Malcherek, Georg, Nan Jin, Angela Hückelhoven, et al.. (2014). Mesenchymal stromal cells inhibit proliferation of virus-specific CD8+ T cells. Leukemia. 28(12). 2388–2394. 23 indexed citations
12.
Wang, Lei, Nan Jin, Anita Schmitt, et al.. (2014). T cell‐based targeted immunotherapies for patients with multiple myeloma. International Journal of Cancer. 136(8). 1751–1768. 11 indexed citations
13.
Jin, Nan, Georg Malcherek, Jiju Mani, et al.. (2013). Suppression of cytomegalovirus-specific CD8+T cells by everolimus. Leukemia & lymphoma. 55(5). 1144–1150. 5 indexed citations
14.
15.
Casalegno‐Garduño, Rosaely, Claudia Meier, Jiju Mani, et al.. (2011). Expression of RHAMM and WT1 As Well As T Cell Responses to These Antigens Before and After Allogeneic Stem Cell Transplantation in Patients with Leukemia. Blood. 118(21). 4315–4315. 1 indexed citations
16.
Wang, Xinchao, Anita Schmitt, Baoan Chen, et al.. (2010). Streptamer-based selection of WT1-specific CD8+ T cells for specific donor lymphocyte infusions. Experimental Hematology. 38(11). 1066–1073. 18 indexed citations
17.
Iyer, Ramya, Sudhir Kumar Tomar, Suman Kapila, Jiju Mani, & Prashant Singh. (2009). Probiotic properties of folate producing Streptococcus thermophilus strains. Food Research International. 43(1). 103–110. 53 indexed citations
18.
Bhardwaj, Arun, Suman Kapila, Jiju Mani, & R. K. Malik. (2008). Comparison of susceptibility to opsonic killing by in vitro human immune response of Enterococcus strains isolated from dairy products, clinical samples and probiotic preparation. International Journal of Food Microbiology. 128(3). 513–515. 17 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Oelkrug Breakdown of academic impact, for papers by Rajwardhan Yadav Breakdown of academic impact, for papers by Michaela Friedrichsen Breakdown of academic impact, for papers by Mingju Hao Breakdown of academic impact, for papers by Nichole Escalante Breakdown of academic impact, for papers by Adovi Akue Breakdown of academic impact, for papers by Steven A. Erickson Breakdown of academic impact, for papers by Maureen L. Drakes Breakdown of academic impact, for papers by Richard B. Sisson Breakdown of academic impact, for papers by Jihoon Chang
Rankless by CCL
2026